✦ LIBER ✦

4-Hydroxyandrostenedione (4-OHA) as first line treatment in postmenopausal patients with advanced breast cancer(ABC)

✍ Scribed by Zilembo, N.; Bajetta, E.; Noberasco, C.; Buzzoni, R.; Martinetti, A.; Ferrari, L.; Galante, E.; Fariselli, G.; Piromalli, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

702 - 4-hydroxyandrostenedione (4-OHA) a

✍ C.S. Gennatas; J. Psychogios; C. Dardoufas; N. Tsavaris; S. Athanasiadis 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

A randomized study with 4-hydroxyandrost

✍ Bajetta, E.; Zilembo, N.; Buzzoni, R.; Noberasco, C.; Sacchini, V.; La Monica, G 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Efficacy and tolerability of 4-hydroxyan

✍ Bajetta, Emilio; Zilembo, Nicoletta; Buzzoni, Roberto; Noberasco, Cristina; Celi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 392 KB

4-Hydroxyandrostenedione treatment for p

✍ R.Charles Coombes; Paul E. Goss; Mitchell Dowsett; Gillian Hutchinson; David Cun 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 371 KB

4-HYDROXYANDROSTENEDIONE IN TREATMENT OF

✍ Coombes, R.Charles; Dowsett, Mitch; Goss, Paul; Gazet, J-C.; Brodie, Angela 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 352 KB

4-Hydroxyandrostenedione treatment for p

✍ Coombes, R.C. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 269 KB